NMDA receptor antagonism with novel indolyl, 2-(1,1-Dimethyl-1,3-dihydro-benzo[e]indol-2-ylidene)-malonaldehyde, reduces seizures duration in a rat model of epilepsy-Reference-Cited by-同舟云学术

NMDA receptor antagonism with novel indolyl, 2-(1,1-Dimethyl-1,3-dihydro-benzo[e]indol-2-ylidene)-malonaldehyde, reduces seizures duration in a rat model of epilepsy

Published:2017-03-30 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Rothan Hussin A.,Amini Elham,Faraj Fadihl L.,Golpich Mojtaba,Teoh Teow Chong,Gholami Khadijeh,Yusof Rohana

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep45540.pdf

Reference49 articles.

1. Fabene, P. F., Bramanti, P. & Constantin, G. The emerging role for chemokines in epilepsy. J Neuroimmunol. 224, 22–27 (2010).

2. Hwang, H. & Kim, K. J. New antiepileptic drugs in pediatric epilepsy. Brain Dev. 30, 549–555 (2008).

3. Asano, E., Juhasz, C., Shah, A., Sood, S. & Chugani, H. T. Role of subdural electrocorticography in prediction of long-term seizure outcome in epilepsy surgery. Brain. 132, 1038–1047 (2009).

4. Sebe, J. Y. & Baraban, S. C. The promise of an interneuron-based cell therapy for epilepsy. Dev Neurobiol. 71, 107–117 (2011).

5. Naegele, J. R., Maisano, X., Yang, J., Royston, S. & Ribeiro, E. Recent advancements in stem cell and gene therapies for neurological disorders and intractable epilepsy. Neuropharmacology. 58, 855–864 (2010).

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies;Journal of Medicinal Chemistry;2023-04-04

2. Synthesis, Characterization and Cytotoxicity Activity Study of Some Chalcones Derived from 2-(1,1-dimethyl-1,3-dihydro-2H-benzo[e]indol-2-ylidene)malonaldehyde;Journal of the Turkish Chemical Society Section A: Chemistry;2022-11-02

3. Targeting NMDA Receptor Complex in Management of Epilepsy;Pharmaceuticals;2022-10-21

4. Pathological Targets for Treating Temporal Lobe Epilepsy: Discoveries From Microscale to Macroscale;Frontiers in Neurology;2022-01-07

5. (3 + 2) cycloaddition of 2-alkoxynaphthalenes with azaoxyallyl cations: access to benzo[e]indolones;Organic & Biomolecular Chemistry;2022